H2 Medical

H2 Medical is a Japanese medical technology company specializing in the development and commercialization of hydrogen gas inhalation therapy. The company focuses on treating acute and chronic conditions characterized by oxidative stress and inflammation, such as post-cardiac arrest syndrome and myocardial infarction. Their core technology involves high-purity hydrogen generators designed for clinical environments, specifically the MHG-2000 system. H2 Medical is currently advancing several clinical programs in Japan to establish hydrogen inhalation as a standard of care in emergency and intensive medicine. The company's research is supported by collaborations with leading academic institutions, including Keio University.